Based in New York, NeuroNetworks Fund is a not-for-profit venture capital firm focused on accelerating the time to market for much-needed drugs, diagnostics, and medical products for patients with neurological disorders. By combining venture capital and philanthropy, the fund aims to close the gap between groundbreaking research and the companies that bring products to market. Their initial focus on autism, epilepsy, and schizophrenia allows them to leverage shared genetic and biochemical pathways, translating innovative research into marketable products. As a not-for-profit organization, all investment returns are reinvested to support additional projects and novel research, making a difference in the field.